New Key Statistics Module, Z-Score and F-Score
NAS:SONN Key Ratios
| Market Cap $ M | 2.74 |
| Enterprise Value $ M | -0.88 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.90 |
| Price/Sales | 16.30 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -5.20 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.07 |
| EV-to-EBITDA | 0.07 |
| PEG | -- |
| Shares Outstanding M | 3.11 |
| Net Margin (%) | -9,062.37 |
| Operating Margin % | -13,616.13 |
| Pre-tax Margin (%) | -9,062.37 |
| Quick Ratio | 1.89 |
| Current Ratio | 1.89 |
| ROA % (ttm) | -105.29 |
| ROE % (ttm) | -297.03 |
| ROIC % (ttm) | -639.87 |
| Dividend Yield % | -- |
| Altman Z-Score | -29.93 |
SONN Number of Guru Trades
SONN Volume of Guru Trades
Gurus Latest Trades with NAS:SONN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SONN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sonnet BioTherapeutics Holdings Inc Insider Transactions
No Available Data
News about NAS:SONN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers